Clinical Trial Update: A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 safety study comparing Natrecor (Nesiritide) to Dobutamine for worsening congestive heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dobutamine (dobutamine)
• Natrecor (nesiritide)

Snippet

Sponsor: Scios, Inc. | Conditions: Heart Failure, Congestive | Phase 3 | Status: COMPLETED